Basic Study
Copyright ©The Author(s) 2022.
World J Hepatol. Aug 27, 2022; 14(8): 1562-1575
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1562
Table 3 Studied miRNAs in healthy controls vs hepatocellular carcinoma

Controls
HCC patients
P value
N = 25N = 70
miRNA-3261.2 (0.3- 30.8)35.0 (12.5- 162.3)0.001b
miRNA-5112.1 (0.9- 7.7)1.2 (0.3- 3.2)0.02a
miRNA-4246.1 (0.7- 12.4)5.1 (2.9- 10.3)0.4